People of all ages can get norovirus, but more severe infections occur in children younger than five years old, older adults and people with weakened immune systems. Symptoms typically develop within ...
Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...
Hospitals have been directed to report cases of Influenza-like Illness (ILI) and Severe Acute Respiratory Infection (SARI) through the IHIP Portal without delay.